Who owns GT BIOPHARMA INC COM NEW?

Tip: Access positions for across all investors

Analyze quarterly positions in Gt Biopharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Gt Biopharma stock

Who bought or sold GT BIOPHARMA INC COM NEW this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
DekaBank Deutsche Girozentrale 1.1M $47M 100% Mar 2024
 View chart
Advisory Services Network 150.00 $37.995000 100% Dec 2023
 View chart
Front Row Advisors 58.00 $14.998800 100% Dec 2023
 View chart